O'Brien SM - Search Results

1

Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.

Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: o brien sm. Future Oncol. 2024 Apr;20(12):717-726. doi: 10.2217/fon-2023-0849. Epub 2023 Dec 13. Future Oncol. 2024. PMID: 39132937

2

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB. Keating MJ, et al. J Clin Oncol. 1991 Jan;9(1):44-9. doi: 10.1200/JCO.1991.9.1.44. J Clin Oncol. 1991. PMID: 1702145 Clinical Trial.

3

Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia.

Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Keating MJ. Robertson LE, et al. Leukemia. 1995 Jun;9(6):943-5. Leukemia. 1995. PMID: 7596181 Clinical Trial.

4

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.

O'Brien S, Kantarjian H, Beran M, Robertson LE, Koller C, Lerner S, Keating MJ. O'Brien S, et al. Blood. 1995 Aug 15;86(4):1298-300. Blood. 1995. PMID: 7632936 Clinical Trial.

5

A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.

Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Plunkett W, Keating MJ. Robertson LE, et al. Leukemia. 1995 Sep;9(9):1444-9. Leukemia. 1995. PMID: 7658710

6

Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.

Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ. Robertson LE, et al. Leukemia. 1994 Dec;8(12):2047-51. Leukemia. 1994. PMID: 7807993

7

Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

O'Brien S, del Giglio A, Keating M. O'Brien S, et al. Blood. 1995 Jan 15;85(2):307-18. Blood. 1995. PMID: 7811987 Free article. Review.

8

Topotecan in chronic lymphocytic leukemia.

O'Brien S, Kantarjian H, Ellis A, Zwelling L, Estey E, Keating M. O'Brien S, et al. Cancer. 1995 Mar 1;75(5):1104-8. doi: 10.1002/1097-0142(19950301)75:5<1104::aid-cncr2820750509>3.0.co;2-b. Cancer. 1995. PMID: 7850708 Clinical Trial.

9

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.

O'Brien S, Kantarjian H, Estey E, Koller C, Robertson B, Beran M, Andreeff M, Pierce S, Keating M. O'Brien S, et al. N Engl J Med. 1994 Feb 3;330(5):319-22. doi: 10.1056/NEJM199402033300504. N Engl J Med. 1994. PMID: 7904047 Free article.

10

Nucleoside analogs in treatment of chronic lymphocytic leukemia.

Keating MJ, O'Brien S, Kantarjian H, Robertson LB, Koller C, Beran M, Estey E. Keating MJ, et al. Leuk Lymphoma. 1993;10 Suppl:139-45. doi: 10.3109/10428199309149126. Leuk Lymphoma. 1993. PMID: 8097653 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters